Louise E Donnelly Selected Research

Louise E Donnelly Research Topics

Disease

43	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 05/2002
17	Inflammation (Inflammations) 01/2022 - 04/2002
12	Asthma (Bronchial Asthma) 01/2019 - 01/2002
6	Disease Progression 01/2023 - 01/2003
4	Lung Diseases (Lung Disease) 01/2021 - 01/2018
2	Human Influenza (Influenza) 05/2024 - 01/2021
2	Fibrosis (Cirrhosis) 12/2023 - 01/2019
2	COVID-19 01/2022 - 01/2021
2	Necrosis 01/2022 - 01/2003
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Infections 11/2020 - 01/2019
1	Clinical Deterioration 05/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2023
1	Emphysema 01/2021
1	Fever (Fevers) 01/2021
1	Airway Remodeling 01/2021
1	Common Cold 01/2021
1	Pneumococcal Infections 11/2020

Drug/Important Bio-Agent (IBA)

8	SmokeIBA 01/2022 - 01/2003
6	CytokinesIBA 01/2022 - 01/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2003
6	ChemokinesIBA 01/2022 - 10/2006
5	Budesonide (Pulmicort)FDA LinkGeneric 05/2024 - 01/2014
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2003
4	InterleukinsIBA 01/2022 - 01/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2003 - 01/2002
3	CC ChemokinesIBA 01/2022 - 08/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
3	SteroidsIBA 01/2021 - 01/2002
3	AntioxidantsIBA 01/2018 - 03/2011
3	Interleukin-8 (Interleukin 8)IBA 01/2008 - 01/2003
3	EnzymesIBA 01/2008 - 10/2002
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 04/2016
2	Poly I-CIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 01/2017
2	Macrophage Colony-Stimulating FactorIBA 10/2019 - 01/2018
2	AntagomirsIBA 01/2019 - 01/2019
2	CXC ChemokinesIBA 04/2016 - 08/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015 - 01/2003
2	Chemokine ReceptorsIBA 01/2015 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 01/2008
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Syntex adjuvant formulationIBA 12/2023
1	GalactosidasesIBA 12/2023
1	Neutralizing AntibodiesIBA 01/2022
1	Interleukin-33IBA 01/2022
1	InterferonsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	HepcidinsIBA 11/2020
1	metal transporting protein 1 (ferroportin)IBA 11/2020
1	IronIBA 11/2020
1	Peptide Hormones (Polypeptide Hormones)IBA 11/2020
1	Insulin (Novolin)FDA Link 02/2020
1	Hemoglobins (Hemoglobin)IBA 02/2020
1	Bronchodilator Agents (Bronchodilators)IBA 02/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	SirtuinsIBA 01/2020
1	SenotherapeuticsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	Galectin 3 (LGALS3)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	RoflumilastIBA 01/2019
1	Leukotriene B4IBA 01/2019
1	Sirtuin 1IBA 01/2019
1	Phosphodiesterase 4 InhibitorsIBA 01/2019
1	16S Ribosomal RNAIBA 01/2018
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2018
1	AntibodiesIBA 01/2018
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 10/2017
1	superoxide dismutase 2IBA 10/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	ResveratrolIBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2017
1	TensinsIBA 01/2017
1	Cell Surface ReceptorsIBA 01/2017
1	isorhapontigeninIBA 01/2017
1	PolyphenolsIBA 01/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2016
1	GoldIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	N- methyl- 3- (((4- pyridin- 4- ylbenzoyl)amino)methyl)benzamideIBA 01/2016
1	rho-Associated KinasesIBA 01/2016
1	Janus Kinase InhibitorsIBA 01/2015
1	PF 956980IBA 01/2015
1	C-Reactive ProteinIBA 09/2014
1	Fibrinogen (Factor I)FDA Link 09/2014
1	PercollIBA 01/2014

Therapy/Procedure

11	Therapeutics 03/2024 - 01/2003
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2006
1	Ambulatory Care (Outpatient Care) 05/2024
1	Complementary Therapies (Alternative Medicine) 01/2022